Jessica Chubak, PhD

“My research focuses on improving cancer control by finding effective ways to get screened for cancer and to navigate treatment and survivorship.”

Jessica Chubak, PhD

Group Health Research Institute Associate Investigator

Biography

Jessica Chubak works to improve cancer diagnosis, treatment, control, and survivorship. She is the Group Health Research Institute (GHRI) principal investigator for the National Cancer Institute's Cancer Research Network. She contributes to several national collaborations that are finding practical, efficient, effective ways to screen for cancer, especially colorectal cancer. She also studies how common medications affect cancer risk and recurrence. Based on a personal interest in how pets positively affect health, Dr. Chubak is studying animal-assisted activities in clinics and hospitals where children get treated for cancer. Dr. Chubak’s methodological research focuses on the use of administrative and electronic health record data.

Dr. Chubak joined GHRI in 2007, bringing expertise in epidemiologic methods, pharmaco-epidemiology, and cancer. Awarded a Fulbright graduate student grant, Dr. Chubak pursued her master's degree in bioethics and health law in New Zealand. Dr. Chubak is an affiliate associate professor in the Department of Epidemiology at the University of Washington School of Public Health. A member of the American Society of Preventive Oncology and the Society for Epidemiologic Research, she also serves as a peer reviewer for a dozen journals, including Journal of the National Cancer Institute, Journal of Oncology Practice, and the Journal of Clinical Epidemiology.

Research interests and experience

  • Cancer

    Epidemiology; colorectal cancer; medication use; survivorship; secondary prevention; quality of life; automated data collection; screening; animal-assisted activities; survivorship

  • Health Services & Economics

    Chronic illness management; translation of preventive care research into clinical practice

  • Medication Use & Patient Safety

    Cancer risk and use of common medications; pharmaceutical outcomes research; validation of pharmacy data resources

 

Recent publications

Meenan RT, Anderson ML, Chubak J, Vernon SW, Fuller S, Wang CY, Green BB. An economic evaluation of colorectal cancer screening in primary care practice. Am J Prev Med. 2015;48(6):714-21. doi: 10.1016/j.amepre.2014.12.016. PubMed

Chubak J, Onega T, Zhu W, Buist DS, Hubbard RA. An electronic health record-based algorithm to ascertain the date of second breast cancer events. Med Care. 2015 Apr 3. [Epub ahead of print]. PubMed

Ludman EJ, McCorkle R, Bowles EA, Rutter CM, Chubak J, Tuzzio L, Jones S, Reid RJ, Penfold R, Wagner EH. Do depressed newly diagnosed cancer patients differentially benefit from nurse navigation? Gen Hosp Psychiatry. 2015 Feb 28. pii: S0163-8343(15)00038-9. doi: 10.1016/j.genhosppsych.2015.02.008 [Epub ahead of print]. PubMed

Chubak J, Hubbard RA, Johnson E, Kamineni A, Rutter CM. Assessing the effectiveness of a cancer screening test in the presence of another screening modality. J Med Screen. 2014 Dec 9. pii: 0969141314562036 [Epub ahead of print]. PubMed

 

Healthy Findings blog

Dr. Jessica Chubak and team ROAR: Research on Animal-human Relationships

A study to help kids with cancer get time with pets begins field work, with encouragement from a GHRI interest group.

Read about it in Healthy Findings.

Latest news

Home tests and automated reminders cut colon cancer screening costs

With Kaiser Permanente colleagues, Group Health finds cost savings for two years.

Read about it in News and Events.